MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1.
CONCLUSIONS: Downregulated microRNA-373-3p promoted the proliferation of prostate cancer cells via targeting AKT1.
PMID: 30338790 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Benign Prostatic Hyperplasia | Cancer | Cancer & Oncology | Drugs & Pharmacology | Genetics | Prostate Cancer | Study